Evidence map›Paper›PMID 38420531›Full record

ArticleJTCVS open2024

Midterm follow-up of composite graft replacement of the aortic root (30-year experience)-remarkably safe, effective, and durable.

Syeda Manahil Haider Jeoffrey, Mohammad A Zafar, Juan Velasco, Ahad Khattak, Hesham Ellauzi, Afsheen Nasir, Asanish Kalyanasundaram, Bulat A Ziganshin, John A Elefteriades

Open access · goldAbstract read
In one paragraph

Article in JTCVS open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Syeda Manahil Haider JeoffreyAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.
Mohammad A ZafarAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.
Juan VelascoAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.
Ahad KhattakAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.
Hesham EllauziAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.
Afsheen NasirAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.
Asanish KalyanasundaramAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.
Bulat A ZiganshinAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.
John A ElefteriadesAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.
Yale New Haven Hospital · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Objectives: Contemporary operative choices for aortic root disease include aortic root replacement (ARR) and a variety of valve-sparing and aortic root-repair procedures. We evaluate ultra-long-term outcomes of ARR, focusing on survival, freedom from late reoperation, and adverse events. Methods: Prospectively kept records were used to accomplish long-term follow-up of patients who underwent ARR (4-pronged Yale survival assessment paradigm). Results: Between 1990 and 2020, 564 patients underwent ARR (mean 56 years, 84% male). A modified Cabrol procedure (Dacron coronary graft) was employed in 9.0% (51/564) and concomitant coronary artery bypass grafting in 9.4% (53/564). There were 12.8% (72/564) urgent/emergent and 7.4% (42/564) redo procedures. Operative mortality occurred in 12 patients (2.1%) overall, or 1.4% (8/554) of nondissection and 1.3% (6/468) of elective first-time operations. Six of the 12 deaths presented with acute type A dissection, urgent operation, or reoperative states. Operative mortality dropped to 0.6% during the past 10 years. In total, 11 patients developed endocarditis. Stroke occurred in 11 of 564 patients (2.0%), 4 of whom had presented with type A dissection. Late events included bleeding in 2.8% (16/564), thromboembolism in 1.4% (8/564), and reoperation of the root in 5 of 564 (0.9%) at 15 years and more distal aortic segments in 16/564 (2.8%). Survival was no different from age/sex-matched controls. Conclusions: This ultra-long-term experience finds ARR to be extraordinarily safe, effective, and durable, with minimal long-term bleeding, thromboembolism, or graft failure. This experience provides a standard of durability for ARR against which ultra-long-term outcomes with alternate procedures (valve-sparing, Ross, other) may be compared.

Indexed as

aortic root repairaortic root replacementCabrol procedurecomposite aortic graftDacron coronary graftvalve sparing

Identifiers

PMID38420531
PMCPMC10897671
OpenAlexW4388802683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.